{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:08:32Z","timestamp":1793214512020,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jns.2024.123161","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:29:23Z","timestamp":1722972563000},"page":"123161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Environmental factors related to multiple sclerosis progression"],"prefix":"10.1016","volume":"464","author":[{"given":"Riadh","family":"Gouider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Souissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saloua","family":"Mrabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alya","family":"Gharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Abida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imen","family":"Kacem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Gargouri-Berrechid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2024.123161_bb0010","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1177\/1352458517726866","article-title":"Air pollution is associated to the multiple sclerosis inflammatory activity as measured by brain MRI","volume":"24","author":"Bergamaschi","year":"2018","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"7","key":"10.1016\/j.jns.2024.123161_bb0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028951","article-title":"Genetics of multiple sclerosis: An overview and new directions","volume":"8","author":"Patsopoulos","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"9","key":"10.1016\/j.jns.2024.123161_bb0020","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: An integrated review","volume":"6","author":"Waubant","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","article-title":"Environmental factors and multiple sclerosis","volume":"7","author":"Ebers","year":"2008","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000381779","article-title":"The EnvIMS study: Design and methodology of an international case-control study of environmental risk factors in multiple sclerosis","volume":"44","author":"Magalhaes","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"8","key":"10.1016\/j.jns.2024.123161_bb0035","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/1352458513513968","article-title":"Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study","volume":"20","author":"Bj\u00f8rnevik","year":"2014","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1352458514546785","article-title":"Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study","volume":"21","author":"Wesnes","year":"2015","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"199","key":"10.1016\/j.jns.2024.123161_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ane.12430","article-title":"Does the changing sex ratio of multiple sclerosis give opportunities for intervention?","volume":"132","author":"Bostr\u00f6m","year":"2015","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1352458515595876","article-title":"Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination","volume":"22","author":"Makhani","year":"2016","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.jns.2024.123161_bb0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0065","doi-asserted-by":"crossref","first-page":"fcac171","DOI":"10.1093\/braincomms\/fcac171","article-title":"Full spectrum of vitamin D immunomodulation in multiple sclerosis: Mechanisms and therapeutic implications","volume":"4","author":"Galoppin","year":"2022","journal-title":"Brain Commun."},{"issue":"15","key":"10.1016\/j.jns.2024.123161_bb0070","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","article-title":"1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis","volume":"93","author":"Cantorna","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0075","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2024.123161_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jns.2017.07.046","article-title":"Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress","volume":"381","author":"Oliveira","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043542","article-title":"Seasonal changes in serum metabolites in multiple sclerosis relapse","volume":"24","author":"Martynova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2024.123161_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.862120","article-title":"Effect of seasonal variation on relapse rate in patients with relapsing-remitting multiple sclerosis in Saudi Arabia","volume":"13","author":"Makkawi","year":"2022","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000092406","article-title":"Does the season or month of birth influence disease progression in multiple sclerosis?","volume":"26","author":"Tremlett","year":"2006","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.6.4.382","article-title":"Epidemiologic evidence for multiple sclerosis as an infection","volume":"6","author":"Kurtzke","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0105","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1186\/s12889-020-09049-x","article-title":"Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom","volume":"20","author":"Kuri","year":"2020","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.jns.2024.123161_bb0110","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.4049\/jimmunol.1103100","article-title":"HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis","volume":"188","author":"Jilek","year":"2012","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2249.2003.02114.x","article-title":"Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis","volume":"132","author":"H\u00f6llsberg","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.87","article-title":"Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis","volume":"6","author":"Pender","year":"2017","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jns.2024.123161_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.coviro.2014.09.016","article-title":"Evidence linking HHV-6 with multiple sclerosis: An update","volume":"9","author":"Leibovitch","year":"2014","journal-title":"Curr. Opin. Virol."},{"issue":"1\u20132","key":"10.1016\/j.jns.2024.123161_bb0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2007.07.002","article-title":"Bacterial toxins and multiple sclerosis","volume":"262","author":"Gay","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"8485","key":"10.1016\/j.jns.2024.123161_bb0135","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(86)90936-0","article-title":"Multiple sclerosis associated with sinusitis: Case-controlled study in general practice","volume":"1","author":"Gay","year":"1986","journal-title":"Lancet (London, England)."},{"issue":"8499","key":"10.1016\/j.jns.2024.123161_bb0140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(86)91970-7","article-title":"Multiple sclerosis and sinusitis","volume":"2","author":"Callaghan","year":"1986","journal-title":"Lancet (London, England)."},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.msard.2013.01.002","article-title":"Staphylococcal immune complexes and myelinolytic toxin in early acute multiple sclerosis lesions-an immunohistological study supported by multifactorial cluster analysis and antigen-imprint isoelectric focusing","volume":"2","author":"Gay","year":"2013","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2024.123161_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11481-007-9066-2","article-title":"Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: Implications for multiple sclerosis","volume":"2","author":"Jana","year":"2007","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1083\/jcb.200307017","article-title":"Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway","volume":"164","author":"Lee","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jns.2024.123161_bb0160","series-title":"Cancer: Disease Control Priorities","article-title":"Global hazards of tobacco and the benefits of smoking cessation and tobacco Taxes","author":"Jha","year":"2015"},{"issue":"Pt 6","key":"10.1016\/j.jns.2024.123161_bb0165","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/brain\/awh471","article-title":"Cigarette smoking and the progression of multiple sclerosis","volume":"128","author":"Hern\u00e1n","year":"2005","journal-title":"Brain"},{"issue":"15","key":"10.1016\/j.jns.2024.123161_bb0170","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/01.wnl.0000277658.78381.db","article-title":"Cigarette smoking and progression in multiple sclerosis","volume":"69","author":"Koch","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2024.123161_bb0175","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/1352458508093679","article-title":"Smoking is a risk factor for early conversion to clinically definite multiple sclerosis","volume":"14","author":"Di Pauli","year":"2008","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0180","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00415-009-0120-2","article-title":"Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis","volume":"256","author":"Pittas","year":"2009","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2024.123161_bb0185","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archneurol.2009.122","article-title":"Smoking and disease progression in multiple sclerosis","volume":"66","author":"Healy","year":"2009","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2024.123161_bb0190","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/WNL.0b013e3181b2a706","article-title":"Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis","volume":"73","author":"Zivadinov","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0195","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1468-1331.2011.03596.x","article-title":"Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis","volume":"19","author":"D\u2019Hooghe","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053996","article-title":"Environmental factors associated with disease progression after the first demyelinating event: Results from the multi-center SET study","volume":"8","author":"Horakova","year":"2013","journal-title":"PLoS One"},{"issue":"Pt 7","key":"10.1016\/j.jns.2024.123161_bb0205","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/brain\/awt139","article-title":"Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study","volume":"136","author":"Manouchehrinia","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jns.2024.123161_bb0210","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamaneurol.2015.1788","article-title":"Effect of smoking cessation on multiple sclerosis prognosis","volume":"72","author":"Ramanujam","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2024.123161_bb0215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jns.2016.09.057","article-title":"Smoking increases the risk of progression in multiple sclerosis: A cohort study in Queensland, Australia","volume":"370","author":"O\u2019Gorman","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.arcmed.2017.03.002","article-title":"Cigarette smoking, alcohol consumption and overweight in multiple sclerosis: Disability progression","volume":"48","author":"Paz-Ballesteros","year":"2017","journal-title":"Arch. Med. Res."},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0225","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/ene.13262","article-title":"Smoking does not influence disability accumulation in primary progressive multiple sclerosis","volume":"24","author":"Javizian","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2024.123161_bb0230","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ntr\/ntx084","article-title":"Smoking cessation and the reduction of disability progression in multiple sclerosis: A cohort study","volume":"20","author":"Tanasescu","year":"2018","journal-title":"Nicotine Tob. Res."},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0235","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00415-021-10750-z","article-title":"Smoking, obesity, and disability worsening in PPMS: An analysis of the INFORMS original trial dataset","volume":"269","author":"Koch","year":"2022","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0240","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/brain\/awab385","article-title":"The impact of smoking cessation on multiple sclerosis disease progression","volume":"145","author":"Rodgers","year":"2022","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0245","article-title":"The relationship between smoking and multiple sclerosis severity in Saudi Arabia","volume":"14","author":"Makkawi","year":"2022","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.jns.2024.123161_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/jnnp-2022-330848","article-title":"Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression","volume":"94","author":"Wu","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.jns.2024.123161_bb0255","article-title":"The effect of smoking on long-term gray matter atrophy and clinical disability in patients with relapsing-remitting multiple sclerosis","volume":"9","author":"Lie","year":"2022","journal-title":"Neurol. (R) Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0260","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/jcbfm.1995.85","article-title":"Nicotine raises the influx of permeable solutes across the rat blood-brain barrier with little or no capillary recruitment","volume":"15","author":"Chen","year":"1995","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"Pt 3","key":"10.1016\/j.jns.2024.123161_bb0265","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/awq371","article-title":"Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis","volume":"134","author":"Hedstr\u00f6m","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jns.2024.123161_bb0270","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/ije\/dyu195","article-title":"Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk","volume":"43","author":"Hedstr\u00f6m","year":"2014","journal-title":"Int. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.jns.2024.123161_bb0275","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10654-017-0250-2","article-title":"The interaction between smoking and HLA genes in multiple sclerosis: Replication and refinement","volume":"32","author":"Hedstr\u00f6m","year":"2017","journal-title":"Eur. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.jns.2024.123161_bb0280","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/1352458516671028","article-title":"Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study","volume":"23","author":"Bj\u00f8rnevik","year":"2017","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"19","key":"10.1016\/j.jns.2024.123161_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910845","article-title":"Adipokines as immune cell modulators in multiple sclerosis","volume":"22","author":"Rijnsburger","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2024.123161_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29245\/2572.942X\/2016\/7.1064","article-title":"Obesity and multiple sclerosis susceptibility: A review","volume":"1","author":"Gianfrancesco","year":"2016","journal-title":"J. Neurol. Neuromed."},{"issue":"10","key":"10.1016\/j.jns.2024.123161_bb0295","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1177\/1352458519853473","article-title":"Obesity worsens central inflammation and disability in multiple sclerosis","volume":"26","author":"Stampanoni Bassi","year":"2020","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"24","key":"10.1016\/j.jns.2024.123161_bb0300","doi-asserted-by":"crossref","first-page":"e2256","DOI":"10.1212\/WNL.0000000000006644","article-title":"Body mass index, but not vitamin D status, is associated with brain volume change in MS","volume":"91","author":"Mowry","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.arcmed.2017.03.002","article-title":"Cigarette smoking, alcohol consumption and overweight in multiple sclerosis: Disability progression","volume":"48","author":"Paz-Ballesteros","year":"2017","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.jns.2024.123161_bb0310","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fneur.2018.00232","article-title":"Association of pre-disease body mass index with multiple sclerosis prognosis","volume":"9","author":"Manouchehrinia","year":"2018","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2024.123161_bb0315","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/13524585211061861","article-title":"Body mass index as a predictor of MS activity and progression among participants in BENEFIT","volume":"28","author":"Manuel Escobar","year":"2022","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"2","key":"10.1016\/j.jns.2024.123161_bb0320","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/1352458517694088","article-title":"Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study","volume":"24","author":"Wesnes","year":"2018","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"6","key":"10.1016\/j.jns.2024.123161_bb0325","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1007\/s00415-021-10935-6","article-title":"Fitness, physical activity, and exercise in multiple sclerosis: A systematic review on current evidence for interactions with disease activity and progression","volume":"269","author":"Proschinger","year":"2022","journal-title":"J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jns.2024.123161_bb0330","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2012.08.033","article-title":"Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis","volume":"323","author":"Motl","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123161_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103046","article-title":"Childhood pet ownership and multiple sclerosis: A systematic review and meta-analysis","volume":"53","author":"Edwards","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.jns.2024.123161_bb0340","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrneurol.2012.136","article-title":"The benefits of exercise training in multiple sclerosis","volume":"8","author":"Motl","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2024.123161_bb0345","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11910-019-1002-3","article-title":"Exercise as medicine in multiple sclerosis-time for a paradigm shift: preventive, symptomatic, and disease-modifying aspects and perspectives","volume":"19","author":"Dalgas","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.jns.2024.123161_bb0350","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1756285611430719","article-title":"Exercise and disease progression in multiple sclerosis: Can exercise slow down the progression of multiple sclerosis?","volume":"5","author":"Dalgas","year":"2012","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jns.2024.123161_bb0355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.21668\/health.risk\/2019.3.07.eng","article-title":"Environmental factors in multiple sclerosis, focusing exposure to organic solvents","volume":"3","author":"Bostr\u00f6m","year":"2019","journal-title":"Health Risk Anal."},{"issue":"10","key":"10.1016\/j.jns.2024.123161_bb0360","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.neurol.2019.07.014","article-title":"Organic solvent exposure as a risk factor for multiple sclerosis: An updated review","volume":"175","author":"Landtblom","year":"2019","journal-title":"Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0365","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0370","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41598-022-27169-9","article-title":"Potentially toxic elements in the brains of people with multiple sclerosis","volume":"13","author":"Pamphlett","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jns.2024.123161_bb0375","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/1028415X.2016.1239399","article-title":"The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary","volume":"21","author":"Alizadeh-Ghodsi","year":"2018","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.jns.2024.123161_bb0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fpubh.2020.00014","article-title":"Environmental and health impacts of air pollution: A review","volume":"8","author":"Manisalidis","year":"2020","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jns.2024.123161_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110386","article-title":"Association between air pollution and multiple sclerosis: A systematic review","volume":"196","author":"Noorimotlagh","year":"2021","journal-title":"Environ. Res."},{"issue":"5","key":"10.1016\/j.jns.2024.123161_bb0390","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/ane.13223","article-title":"Air pollution, a possible risk factor for multiple sclerosis","volume":"141","author":"T\u00fcrk B\u00f6r\u00fc","year":"2020","journal-title":"Acta Neurol. Scand."},{"issue":"3\u20134","key":"10.1016\/j.jns.2024.123161_bb0395","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000368553","article-title":"Potential impact of air pollution on multiple sclerosis in Tehran, Iran","volume":"43","author":"Heydarpour","year":"2014","journal-title":"Neuroepidemiology"},{"issue":"12","key":"10.1016\/j.jns.2024.123161_bb0400","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1177\/1352458517726866","article-title":"Air pollution is associated to the multiple sclerosis inflammatory activity as measured by brain MRI","volume":"24","author":"Bergamaschi","year":"2018","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"key":"10.1016\/j.jns.2024.123161_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110386","article-title":"Association between air pollution and multiple sclerosis: A systematic review","volume":"196","author":"Noorimotlagh","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.jns.2024.123161_bb0410","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.envres.2017.03.049","article-title":"Air pollution by particulate matter PM(10) may trigger multiple sclerosis relapses","volume":"156","author":"Roux","year":"2017","journal-title":"Environ. Res."},{"key":"10.1016\/j.jns.2024.123161_bb0415","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21668\/health.risk\/2020.3.20.eng","article-title":"Air pollution as a contributing factor of relapses and cases of multiple sclerosis","volume":"3","author":"Zhukovsky","year":"2020","journal-title":"Health Risk Anal."},{"issue":"41","key":"10.1016\/j.jns.2024.123161_bb0420","doi-asserted-by":"crossref","first-page":"58142","DOI":"10.1007\/s11356-021-14577-z","article-title":"Association between ambient air pollution and multiple sclerosis: A systemic review and meta-analysis","volume":"28","author":"Tang","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"14","key":"10.1016\/j.jns.2024.123161_bb0425","doi-asserted-by":"crossref","first-page":"17802","DOI":"10.1007\/s11356-020-11761-5","article-title":"Association of the global distribution of multiple sclerosis with ultraviolet radiation and air pollution: An ecological study based on GBD data","volume":"28","author":"Kazemi Moghadam","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0430","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/ije\/dyac234","article-title":"Association between exposure to combustion-related air pollution and multiple sclerosis risk","volume":"52","author":"Hedstr\u00f6m","year":"2023","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jns.2024.123161_bb0435","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.envres.2015.11.017","article-title":"Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy","volume":"145","author":"Angelici","year":"2016","journal-title":"Environ. Res."},{"key":"10.1016\/j.jns.2024.123161_bb0440","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.envint.2017.07.013","article-title":"Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses","volume":"109","author":"Palacios","year":"2017","journal-title":"Environ. Int."},{"key":"10.1016\/j.jns.2024.123161_bb0445","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2018.02.019","article-title":"An 8-year study of people with multiple sclerosis in Isfahan, Iran: Association between environmental air pollutants and severity of disease","volume":"319","author":"Ashtari","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0450","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13311-017-0587-y","article-title":"The role of the gut microbiome in multiple sclerosis risk and progression: Towards characterization of the \u201cMS microbiome\u201d","volume":"15","author":"Pr\u00f6bstel","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"19","key":"10.1016\/j.jns.2024.123161_bb0455","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","article-title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course","volume":"185","author":"iMSMS Consortium","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jns.2024.123161_bb0460","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2016.02.042","article-title":"Gut microbiota composition and relapse risk in pediatric MS: A pilot study","volume":"363","author":"Tremlett","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123161_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.604179","article-title":"The gut-brain Axis: How microbiota and host inflammasome influence brain physiology and pathology","volume":"11","author":"Rutsch","year":"2020","journal-title":"Front. Immunol."},{"issue":"7374","key":"10.1016\/j.jns.2024.123161_bb0470","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2024.123161_bb0475","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1073\/pnas.1000082107","article-title":"Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis","volume":"108 Suppl 1","author":"Lee","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.jns.2024.123161_bb0480","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s11940-015-0344-7","article-title":"The gut microbiome in multiple sclerosis","volume":"17","author":"Mielcarz","year":"2015","journal-title":"Curr. Treat. Options Neurol."},{"issue":"7","key":"10.1016\/j.jns.2024.123161_bb0485","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.4049\/jimmunol.1001443","article-title":"Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide a expression","volume":"185","author":"Ochoa-Rep\u00e1raz","year":"2010","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"40","key":"10.1016\/j.jns.2024.123161_bb0490","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jns.2024.123161_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.718220","article-title":"The gut-brain axis in multiple sclerosis. Is its dysfunction a pathological trigger or a consequence of the disease?","volume":"12","author":"Parodi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jns.2024.123161_bb0500","doi-asserted-by":"crossref","first-page":"1146748","DOI":"10.3389\/fnut.2023.1146748","article-title":"Gut microbiome-modulated dietary strategies in EAE and multiple sclerosis","volume":"10","author":"Hoffman","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jns.2024.123161_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.960761","article-title":"Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis","volume":"13","author":"Moles","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jns.2024.123161_bb0510","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cmet.2018.05.006","article-title":"Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota","volume":"27","author":"Cignarella","year":"2018","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0515","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3920\/BM2018.0029","article-title":"Multiple sclerosis and faecal microbiome transplantation: Are you going to eat that?","volume":"10","author":"Wing","year":"2019","journal-title":"Benefic. Microbes"},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0520","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ane.13516","article-title":"Impact of comorbidities on the disability progression in multiple sclerosis","volume":"145","author":"Maric","year":"2022","journal-title":"Acta Neurol. Scand."},{"issue":"1\u20132","key":"10.1016\/j.jns.2024.123161_bb0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2014.10.020","article-title":"Vascular comorbidities in the onset and progression of multiple sclerosis","volume":"347","author":"Tettey","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123161_bb0530","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fneur.2020.00851","article-title":"Comorbidity in multiple sclerosis","volume":"11","author":"Magyari","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0535","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"issue":"13","key":"10.1016\/j.jns.2024.123161_bb0540","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0545","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/ene.14608","article-title":"The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis","volume":"28","author":"Petruzzo","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2024.123161_bb0550","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/ane.13671","article-title":"Temporal trends of epilepsy in multiple sclerosis","volume":"146","author":"Mahamud","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2024.123161_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102565","article-title":"Prevalence of comorbidities in multiple sclerosis and impact on physical disability according to disease phenotypes","volume":"46","author":"Ciampi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2024.123161_bb0560","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/13524585211046739","article-title":"Epilepsy as a predictor of disease progression in multiple sclerosis","volume":"28","author":"Grothe","year":"2022","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"key":"10.1016\/j.jns.2024.123161_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101497","article-title":"Prognostic impact of epilepsy in multiple sclerosis","volume":"38","author":"Mahamud","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"24","key":"10.1016\/j.jns.2024.123161_bb0570","doi-asserted-by":"crossref","first-page":"e2216","DOI":"10.1212\/WNL.0000000000008617","article-title":"Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study","volume":"93","author":"Binzer","year":"2019","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.jns.2024.123161_bb0575","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1212\/WNL.0000000000005302","article-title":"Psychiatric comorbidity is associated with disability progression in multiple sclerosis","volume":"90","author":"McKay","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2024.123161_bb0580","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10865-010-9247-y","article-title":"Treatment adherence in multiple sclerosis: Association with emotional status, personality, and cognition","volume":"33","author":"Bruce","year":"2010","journal-title":"J. Behav. Med."},{"issue":"2","key":"10.1016\/j.jns.2024.123161_bb0585","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/11533330-000000000-00000","article-title":"Impact of adherence to interferons in the treatment of multiple sclerosis: A non-experimental, retrospective, cohort study","volume":"30","author":"Steinberg","year":"2010","journal-title":"Clin. Drug Investig."},{"issue":"5","key":"10.1016\/j.jns.2024.123161_bb0590","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1037\/hea0000142","article-title":"Examining the moderating effect of depressive symptoms on the relation between exercise and self-efficacy during the initiation of regular exercise","volume":"34","author":"Kangas","year":"2015","journal-title":"Health Psychol."},{"issue":"12","key":"10.1016\/j.jns.2024.123161_bb0595","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1002\/hbm.22992","article-title":"Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression","volume":"36","author":"Rocca","year":"2015","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.jns.2024.123161_bb0600","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1038\/s41598-017-05507-6","article-title":"Subcortical volume and white matter integrity abnormalities in major depressive disorder: Findings from UK biobank imaging data","volume":"7","author":"Shen","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jns.2024.123161_bb0605","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/1352458512463764","article-title":"Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs","volume":"19","author":"Tedeholm","year":"2013","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)."},{"key":"10.1016\/j.jns.2024.123161_bb0610","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fneur.2018.01150","article-title":"The effect of disease modifying therapies on disability progression in multiple sclerosis: A systematic overview of Meta-analyses","volume":"9","author":"Claflin","year":"2018","journal-title":"Front. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2400296X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2400296X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T17:21:09Z","timestamp":1724520069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2400296X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":122,"alternative-id":["S0022510X2400296X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123161","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Environmental factors related to multiple sclerosis progression","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123161"}}